AzTrials
AzTrials

Type 2 Diabetes MellitusNCT04386200

Web-based Approach in Nutrition and Diabetes

A study testing web-based thecnologies and traditional approach in people with Type 2 Diabetes Mellitus and Overweight and Obesity, run by Università degli Studi 'G. d'Annunzio' Chieti e Pescara at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study aims to test web-based strategies, in overweight or obese participants at risk or affected by Type 2 Diabetes Mellitus , to promote adherence over time to a healthy lifestyle and nutritional medical therapy (TMN). Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
web-based thecnologies and traditional approach
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteItaly
Study dates
13 Feb 2019to Oct 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Overweight or obesity (BMI ≥25 kg/m2)
  • Participants with or at risk of Type 2 Diabetes Mellitus
  • Skills in the use web-based technologies and internet accessibility

Who cannot join

  • Conditions that could interfere with the execution and completion of the project or failure adherence to the protocol.

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Hospital "SS Annunziata"

    Chieti, 66100

Other trials in Italy

About this study

Official title: Educational Approach, Clinical Nutrition and Type 2 Diabetes: Traditional Strategies and Innovative Technologies

The study aims to test web-based strategies, in overweight or obese participants at risk or affected by Type 2 Diabetes Mellitus , to promote adherence over time to a healthy lifestyle and nutritional medical therapy (TMN). The study population includes 40 subjects, randomly allocated to web group (therapeutic reinforcement through web-based strategies) or traditional group (traditional educational approach). Anthropometric and clinical parameters will be collected, as well as scores of validated questionnaires will be administered up to 12 months from the enrollment.

Being tested
web-based thecnologies, traditional approach
Keywords
Web technologies, Nutrition
Medical subject headings
Diabetes Mellitus, Type 2, Overweight, Obesity, Nutritional and Metabolic Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • web-based thecnologiesOther

    Integration of "traditional" face-to-face educational approach with web-based technologies.

  • traditional approachBehavioural

    "traditional" face-to-face educational approach

Study groups in NCT04386200
Study groupRoleWhat they receive
WEB GROUPExperimentalTraditional approach integrated with web-based technologies.
Receives: Other: web-based thecnologies
TRADITIONAL GROUPOtherTraditional educational approach
Receives: Behavioral: traditional approach

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline in Body Weight

    Assessment of body weight (in kilograms) at baseline and after 3, 6, 9 and 12 months

    Measured: Baseline, month 3, month 6, month 9 and month12

Secondary outcomes (8)
  1. Change from baseline in BMI

    Assessment of BMI (kg/m^2) at baseline and after 3, 6, 9 and 12 months

    Measured: Baseline, month 3, month 6, month 9 and month12

  2. Change from baseline in body circumferences

    Assessment of body circumferences (in centimeters) at baseline and after 3, 6, 9 and 12 months

    Measured: Baseline, month 3, month 6, month 9 and month12

  3. Change from baseline in Systolic and Diastolic blood pressure

    Assessment of Systolic and Diastolic blood pressure (mm hg) at baseline and after 3, 6, 9 and 12 months

    Measured: Baseline, month 3, month 6, month 9 and month12

  4. Change from baseline in fasting blood glucose

    Assessment of fasting blood glucose (mg/dl) at baseline and after 3, 6, 9 and 12 months

    Measured: Baseline, month 3, month 6, month 9 and month12

  5. Change from baseline in HbA1C

    Assessment of HbA1C at baseline and after 3, 6, 9 and 12 months

    Measured: Baseline, month 3, month 6, month 9 and month12

  6. Change from baseline in Dietary habits estimated by PREvencion con DIetaMEDiterranea questionnaire (PREDIMED questionnaire)

    Assessment of Dietary habits at baseline and after 3, 6, 9 and 12 months. Changes in dietary habits will be estimated using a 14-item PREDIMED questionnaire which is a questionnaire to assess the adherence to the Mediterranean diet, 0 being the minimum total score and 14 the maximum total score. Higher values represent a higher adherence to the Mediterranean diet.

    Measured: Baseline, month 3, month 6, month 9 and month12

  7. Change from baseline in physical activity level estimated by the International Physical Activity Questionnaire (IPAQ) - short form

    Assessment of physical activity level at baseline and after 3, 6, 9 and 12 months. Changes in the level of physical exercise will be estimated by the International Physical Activity Questionnaire (IPAQ-short form) which is a questionnaire to assess the level of physical activity. Patients are asked to measure the average amount of time spent in sedentary behaviours and different intensity levels of physical activity. The questionnaire obtains three different intensity levels of physical activity: low, moderate and high.

    Measured: Baseline, month 3, month 6, month 9 and month12

  8. Change from baseline in Quality of life by 36-item short form health survey (SF-36)

    Assessment of Quality of life by SF-36 at baseline and after 3, 6, 9 and 12 months. The 36-Item Short Form Health Survey (SF-36) is a self-report generic quality of life measure. The SF-36 measures eight scales: physical functioning (PF), role physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH) with scores ranging from 0 to 100. Higher scores indicate greater self-reported quality of life.

    Measured: Baseline, month 3, month 6, month 9 and month12

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 May 2020
  2. Study start13 Feb 2019
  3. Primary completionOct 2020 (estimated)
  4. Study completionOct 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04386200
Sponsor's protocol ID
VITA02
Status last verified
May 2020
First submitted
5 May 2020
Last updated
15 May 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Fraticelli F, Nicola MD, Vitacolonna E. A nutritional web-based approach in obesity and diabetes before and during the COVID-19 lockdown. J Telemed Telecare. 2023 Feb;29(2):91-102. doi: 10.1177/1357633X20966933. Epub 2020 Oct 21.

    PubMed 33081596

Questions about this trial

What is this clinical trial studying?

A study testing web-based thecnologies and traditional approach in people with Type 2 Diabetes Mellitus and Overweight and Obesity, run by Università degli Studi 'G. d'Annunzio' Chieti e Pescara at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 May 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline in Body Weight (time frame: Baseline, month 3, month 6, month 9 and month12). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04386200, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 May 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in